Evidence map›Paper›PMID 26819710›Full record

ArticleMolecular and cellular therapies2016

Interleukin 20 regulates dendritic cell migration and expression of co-stimulatory molecules.

Rikke Bech, Babak Jalilian, Ralf Agger, Lars Iversen, Mogens Erlandsen, Kristian Otkjaer, Claus Johansen, Søren R Paludan, Carina A Rosenberg, Knud Kragballe and 1 more

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular therapies, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Interleukin-24 in type 2 immune diseases.Frontiers in immunology · 2026
    Review
  3. Multifaceted Roles of IL-26 in Physiological and Pathological Conditions.International journal of molecular sciences · 2025
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Molecules (Basel, Switzerland) · 2019
    Article
  12. Article
  13. IL-20 receptor cytokines in autoimmune diseases.Journal of leukocyte biology · 2018
    Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Rikke Bech *Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
Babak Jalilian *Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Ralf AggerDepartment of Health Science and Technology, Aalborg University, Aalborg, Denmark.
Lars IversenDepartment of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
Mogens ErlandsenDepartment of Public Health - Biostatistics, Aarhus University, Aarhus, Denmark.
Kristian OtkjaerDepartment of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
Claus JohansenDepartment of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
Søren R PaludanDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
Carina A RosenbergDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
Knud KragballeDepartment of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
Thomas Vorup-JensenDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
Aarhus University Hospital · DKAarhus University · DKAalborg University · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPsoriasis is an inflammatory disease characterized by leukocyte skin infiltration. Interestingly, recent works suggest that the migration of dendritic cells (DCs) is abnormal in psoriatic skin. DCs have significant role in regulating the function of T lymphocytes, at least in part influenced by the local environment of cytokines. In psoriatic skin lesions the expression of IL-20 is highly up-regulated. It is unclear if this cytokine has any influence on DCs.

methodsHere, we investigated the influence of IL-20 in monocyte-derived dendritic cell (MDDCs) in vitro. This work addressed IL-20 effects on DC maturation, receptor expression and signaling. By use of extra cellular matrix components mimicking the skin environment, we also studied the functional effects of IL-20 on the chemotactic migration of DCs. Based on the recent finding that CD18 integrin are shed during migration of myeloid leukocytes, the concentration of these adhesion molecules was measured in MDDCs culture supernatants post migration.

resultsFollowing stimulation with IL-20, immature human MDDCs enhanced the expression of the co-stimulatory molecule CD86, further enabling activation of the p38 MAPK, but not the STAT3, pathway. IL-20 increased the migration of MDDCs in a biphasic response narrowly controlled by the interleukin concentration. A concomitant change in the shedding of CD18 integrins suggested that these adhesion molecules play a role in the migration of the MDDCs through the extracellular matrix layer.

conclusionTaken together, our findings points to a possible, yet subtle, role of IL-20 in DCs migration. The biphasic response suggests that the aberrant IL-20 expression in psoriasis impedes DC migration, which could be a part of the processes that precipitates the dysregulated inflammatory response associated with this disease.

Indexed as

CD18 integrinsCell migrationDendritic cellsInterleukin (IL)-20Psoriasis

Identifiers

PMID26819710
PMCPMC4728801
OpenAlexW2272524243

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.